Sitbon, O <br/><br/>
Bosentan for the treatment of pulmonary arterial hypertension associated with congenital heart defects.  [electronic resource] 

 -  European journal of clinical investigation  Sep 2006 
 - 25-31 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0014-2972 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2362.2006.01685.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antihypertensive Agents--administration & dosage<br/>Bosentan<br/>Child<br/>Drug Therapy, Combination<br/>Exercise Test--methods<br/>Female<br/>Heart Defects, Congenital--complications<br/>Humans<br/>Hypertension, Pulmonary--complications<br/>Male<br/>Middle Aged<br/>Prostaglandins, Synthetic--therapeutic use<br/>Pulmonary Circulation--drug effects<br/>Retrospective Studies<br/>Sulfonamides--administration & dosage<br/>Treatment Outcome<br/>Vascular Resistance--drug effects<br/>Walking--physiology